Latest News about NVO
Recent news which mentions NVO
From Benzinga
From Benzinga
Regeneron Pharmaceuticals' Approach To Improve Quality Of Weight Loss Has Merit: Goldman Sachs
June 24, 2024
From Benzinga
Will Novo Nordisk Building Fires Serve As A Catalyst For Eli Lilly? Redditors See A Stock Split For US Company 'Very Likely'
June 24, 2024
From Benzinga
From InvestorPlace
7 Strong Buy Blue-Chip Stocks to Keep You in the Green
June 24, 2024
From InvestorPlace
From Benzinga
3 Biotech Stocks to Buy Now: June 2024
June 21, 2024
From InvestorPlace
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
From Benzinga
Tickers
NVO
From Motley Fool
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
June 21, 2024
From Benzinga
From Benzinga
From Benzinga
Eli Lilly Expands Fight Against Counterfeit Obesity Drug Zepbound With New Legal Actions
June 20, 2024
From Benzinga
From InvestorPlace
3 Mega Cap Stock Bargains As Markets Hit All-Time Highs
June 18, 2024
From Benzinga
From Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
June 18, 2024
From Motley Fool
From Motley Fool
3 Best Stocks to Buy From the Fantastic 5
June 17, 2024
From InvestorPlace
Where Will Madrigal Pharmaceuticals Be in 3 Years?
June 15, 2024
From Motley Fool
From Motley Fool
From Benzinga
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
From InvestorPlace
3 Stocks to Sell as Ozempic Surges in Popularity
June 14, 2024
From InvestorPlace
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
June 14, 2024
From Motley Fool
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
June 14, 2024
From Motley Fool
Weight Loss Drugs: Are They Really Magic?
June 13, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.